EP3984528
Lyfjasamsetningar sem innihalda nílótíníb
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.9.2007EP published:
5.7.2023EP application number:
21194622.3
EP translation filed:
24.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
24.9.2027Expiry date:
24.9.2026Next due date:
30.9.2026
Title in English:
PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIBLanguage of the patent:
English
Timeline
Today
25.9.2007EP application
5.7.2023EP Publication
24.7.2023Translation submitted
15.8.2023Registration published
24.9.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Bruneau, NathalieAddress:
06700 Saint-Laurent du Var, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
06121371Date:
27.9.2006Country:
EP
Classification
Categories:
A61K 9/16, A61K 31/506, A61P 35/02, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 11.8.2023
Expires: 24.9.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 23.8.2024
Expires: 24.9.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 15.9.2025
Expires: 24.9.2026
Payer: Árnason Faktor ehf.